ISSN2456-3315
Impact Factor10.57
UGC CAREApproved
Low Cost₹599 / $45
CrossRefDOI
ESTD2016
Peer ReviewTransparent
AccessOpen
Submission: Always Open

Paper Title

Formulation and Characterization of Lercanidipine Loaded Nanoparticles

Authors

Umesh Kumar Chaurasiya , Satyam Vishwakarma

Keywords

hypertension, bioavailability, nanoparticle, ercanidipine, extended release profile

Abstract

Aim of the present study was to investigate the potential of polymeric nanoparticles in improving the biopharmaceutical properties of lercanidipine. Lercanidipine loaded nanoparticles were prepared by modified emulsion-diffusion-solvent evaporation technique. The resulting nanoparticles were freeze dried and then characterized for particle size, zeta potential, encapsulation efficiency, DSC, XRD, AFM, TEM and in vitro drug release. Amongst all the screened batches, optimized batch (B. No. PN-05) exhibited a particle size of 200.2 nm, PDI of 0.130, zeta potential, -20.6 mV and encapsulation efficiency of 77.41%. The AFM analysis illustrated spherical, non-aggregated, smooth particles whereas TEM images showed smooth, regularly spherical homogeneous mass of the particles. DSC studies suggested amorphization of the drug in nanoparticles and same was also observed in XRD diffractograms as reflected by the amorphous humps. The optimized batch exhibited a significantly different drug release profile from that of lercanidipine. It showed an initial rapid release of 17.96% in 1 h and followed an extended release profile releasing 82.74% in 24 h. The novel polymeric lercanidipine nanoparticles demonstrated 2.12-fold increase in absolute bioavailability as compared to free lercanidipine. In conclusion, encapsulation of lercanidipine in nanoparticles forms a sound basis for improving its bioavailability and for better management of hypertension.

How To Cite

Choose the style your journal or department asks for, then copy it. Every version below is generated from this paper's own record.

IJRTI — journal style
"Formulation and Characterization of Lercanidipine Loaded Nanoparticles", IJRTI - International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.10, Issue 12, page no.b284-b299, December-2025, Available :https://ijrti.org/papers/IJRTI2512138.pdf
APA — 7th edition
Chaurasiya, U. K., & Vishwakarma, S. (2025). Formulation and Characterization of Lercanidipine Loaded Nanoparticles. International Journal for Research Trends and Innovation, 10(12), b284-b299. https://ijrti.org/viewpaperforall.php?paper=IJRTI2512138
MLA — 9th edition
Chaurasiya, Umesh Kumar, and Satyam Vishwakarma. "Formulation and Characterization of Lercanidipine Loaded Nanoparticles." International Journal for Research Trends and Innovation, vol. 10, no. 12, 2025, pp. b284-b299, https://ijrti.org/viewpaperforall.php?paper=IJRTI2512138.
Chicago — 17th, bibliography
Chaurasiya, Umesh Kumar, and Satyam Vishwakarma. "Formulation and Characterization of Lercanidipine Loaded Nanoparticles." International Journal for Research Trends and Innovation 10, no. 12 (2025): b284-b299. https://ijrti.org/viewpaperforall.php?paper=IJRTI2512138.
Harvard — author–date
Chaurasiya, U.K. and Vishwakarma, S. (2025) 'Formulation and Characterization of Lercanidipine Loaded Nanoparticles', International Journal for Research Trends and Innovation, 10(12), pp. b284-b299. Available at: https://ijrti.org/viewpaperforall.php?paper=IJRTI2512138
IEEE — numbered reference
U. K. Chaurasiya and S. Vishwakarma, "Formulation and Characterization of Lercanidipine Loaded Nanoparticles," IJRTI, vol. 10, no. 12, pp. b284-b299, Dec. 2025.
Vancouver — biomedical
Chaurasiya UK, Vishwakarma S. Formulation and Characterization of Lercanidipine Loaded Nanoparticles. IJRTI. 2025 Dec;10(12):b284-b299.
AMA — 11th edition
Chaurasiya UK, Vishwakarma S. Formulation and Characterization of Lercanidipine Loaded Nanoparticles. IJRTI. 2025;10(12):b284-b299. Accessed at https://ijrti.org/viewpaperforall.php?paper=IJRTI2512138
BibTeX — Zotero, Mendeley, LaTeX
@article{IJRTI2512138, author = {Umesh Kumar Chaurasiya and Satyam Vishwakarma}, title = {Formulation and Characterization of Lercanidipine Loaded Nanoparticles}, journal = {International Journal for Research Trends and Innovation}, volume = {10}, number = {12}, pages = {b284-b299}, year = {2025}, month = {December}, issn = {2456-3315}, url = {https://ijrti.org/viewpaperforall.php?paper=IJRTI2512138} }
RIS — EndNote, RefWorks
TY - JOUR AU - Chaurasiya, Umesh Kumar AU - Vishwakarma, Satyam TI - Formulation and Characterization of Lercanidipine Loaded Nanoparticles T2 - International Journal for Research Trends and Innovation JA - IJRTI VL - 10 IS - 12 PY - 2025 SN - 2456-3315 UR - https://ijrti.org/viewpaperforall.php?paper=IJRTI2512138 SP - b284-b299 ER -

Issue

Volume 10 Issue 12, December-2025
Pages : b284-b299

Other Publication Details

Paper Reg. ID IJRTI_208419
Published Paper ID IJRTI2512138
Downloads 205,608
Research Area Pharmacy
Country Chhatarpur, Madhya Pradesh, India
Published December 2025

About Publisher

International Journal for Research Trends and Innovation Published by IJRTI (JW Publication)
2456-3315 ISSN
10.57 Impact Factor
2016 ESTD Year
Open Access
Impact Factor 10.57 calculated by Google Scholar and Semantic Scholar.
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 10.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
UGC CARE Approved Journal — Transparent Peer-reviewed journal aligned with UGC’s 2025 suggestive parameters, with CrossRef DOI registration and Scopus Standard metadata on every published paper.

Licence

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
 Disclaimer: The content, data and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses or consequences arising from its use.

Declarations

Funding

No external funding was received for this study.

Conflict of Interest

The authors declare that they have no conflict of interest.

Acknowledgements

The authors would like to thank the reviewers and the editorial board of International Journal for Research Trends and Innovation for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.

Research & Publication Timeline
Indexed, Abstracted & Author Benefits
Just ₹599
Publish in a UGC CARE Approved Journal | Low Cost ₹599 Indian Author | 🌐 $45 USD International
CrossRef/DataCite DOI Google Scholar Transparent Review ISSN Registered 1–2 Days UGC CARE
Submit Paper →